EUVIMEDEUVIMED entdecken
Crossref

Design, synthesis, and biological evaluation of pyrido[3,2-d]pyrimidine derivatives as novel ATR inhibitors

Yunxin Duan, Lili Zhuang, Yerong Xu, Haodong Cheng, Jiawei Xia, Tao Lu, Yadong Chen

Bioorganic Chemistry · 2023-07 · 136 · 106535

DOI: 10.1016/j.bioorg.2023.106535 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2023-07. Verfasst von Yunxin Duan und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Sciences, China Pharmaceutical University, 639 Longmian Avenue, Nanjing 211198, PR China. Hauptthemen laut MEDLINE: Drug Design, Protein Kinase Inhibitors. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: China Pharmaceutical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeting ataxia telangiectasia mutated and Rad3-related (ATR) kinase is being pursued as a new therapeutic strategy for the treatment of advanced solid tumor with specific DNA damage response deficiency. Herein, we report a series of pyrido[3,2-d]pyrimidine derivatives with potent ATR inhibitory activity through structure-based drug design. Among them, the representative compound 10q exhibited excellent potency against ATR in both biochemical and cellular assays. More importantly, 10q exhibited good liver microsomes stability in different species and also showed moderate inhibitory activity against HT-29 cells in combination treatment with the ATM inhibitor AZD1390. Thus, this work provides a promising lead compound against ATR for further study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DesignProtein Kinase InhibitorsAtaxia Telangiectasia Mutated ProteinsPyrimidinesPyridinesQuinolones

Stichwörter der Autor:innen

ATR inhibitorsCyclizationMetabolic stabilityPyrido[3,2-d]pyrimidineSynthetic lethality

Substanzen

Ataxia Telangiectasia Mutated ProteinsProtein Kinase InhibitorsPyrimidinesAZD1390PyridinesQuinolones

Autor:innen und Institutionen

  • School of Sciences, China Pharmaceutical University, 639 Longmian Avenue, Nanjing 211198, PR China.
  • School of Sciences, China Pharmaceutical University, 639 Longmian Avenue, Nanjing 211198, PR China; State Key Laboratory of Natural Medicines, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, PR China.…
  • School of Sciences, China Pharmaceutical University, 639 Longmian Avenue, Nanjing 211198, PR China. Electronic address: ydchen@cpu.edu.cn.

Förderung

  • China Pharmaceutical University

Zitieren

APA

Duan, Y., Zhuang, L., Xu, Y., Cheng, H., Xia, J., Lu, T., & Chen, Y. (2023). Design, synthesis, and biological evaluation of pyrido[3,2-d]pyrimidine derivatives as novel ATR inhibitors. Bioorganic Chemistry, 136, 106535. https://doi.org/10.1016/j.bioorg.2023.106535

Vancouver

Duan Y, Zhuang L, Xu Y, Cheng H, Xia J, Lu T, et al. Design, synthesis, and biological evaluation of pyrido[3,2-d]pyrimidine derivatives as novel ATR inhibitors. Bioorganic Chemistry. 2023;136:106535. doi:10.1016/j.bioorg.2023.106535

BibTeX
@article{Duan2023,
  author = {Duan, Yunxin and Zhuang, Lili and Xu, Yerong and Cheng, Haodong and Xia, Jiawei and Lu, Tao and Chen, Yadong},
  title = {Design, synthesis, and biological evaluation of pyrido[3,2-d]pyrimidine derivatives as novel ATR inhibitors},
  journal = {Bioorganic Chemistry},
  year = {2023},
  volume = {136},
  pages = {106535},
  doi = {10.1016/j.bioorg.2023.106535}
}
Kostenlos starten →